Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Bristol-Myers Squibb Company

TRADE

NYSE: BMYHealthcare / Drug Manufacturers - Major / USA
58.90+1.07+1.85%Vol 6 119 9061Y Perf -8.23%
Oct 17th, 2018 16:00
BID57.20 ASK59.36
Open57.93 Previous Close57.83
Pre-Market58.00 After-Trading59.20
 0.17 0.29%  0.30 0.51%
Target Price
64.22 
Analyst Rating
Moderate Buy 2.23
Potencial %
9.03 
Finscreener Ranking
     40.50
Insiders Trans % 3/6/12M
-/100/-20 
Value Ranking
     32.21
Insiders Value % 3/6/12M
-/100/-95 
Growth Ranking
★★     45.22
Insiders Shares Cnt. % 3/6/12M
-/100/-95 
Income Ranking
★+     38.95
Market Cap (mil)96 274 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
44.50 
Earnings Date
25th Oct 2018

Today's Price Range

57.6659.28

52wk Range

49.9670.05

5 Year PE Ratio Range

17.5082.90

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
-4.20%
3 Months
3.55%
6 Months
12.62%
1 Year
-8.23%
3 Years
-8.17%
5 Years
24.79%

Quotes

Name / TickerPriceChg.Chg.%
BMY58.901.07001.85
AAPL221.19-0.9600-0.43
GOOG1 115.69-5.5900-0.50
MSFT110.71-0.2900-0.26
XOM81.500.30000.37
WFC54.460.73001.36
JNJ139.462.90002.12
FB159.420.64000.40
GE12.190.09000.74
JPM109.831.21001.11
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.20
Current Ratio 1.40
Long Term Debt to Total Capital 0.32
Total Debt to Equity 0.60
Interest Coverage 23.00
Leverage Ratio 3.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin70.20
EBIT Margin20.20
EBITDA Margin23.40
Pre-tax Profit Margin20.10
Profit Margin-2.69
ValuationValueIndustryS&P 500US Markets
PE Ratio 239.60
PB Ratio 7.62
PS Ratios 6.06
Price to Cash Flow 18.60
Price to Free Cash Flow 329.30
Cash Flow Per Share 3.08
Price to Tangible Book20.65
Book Value per Share7.55
Enterprise Value (in ths.)95 161 200
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)16.01
ROE last 12 Months 2.83
Return on Assets (5Y Avg) 7.07
ROA last 12 Months 1.16
Return on Capital (5Y Avg) 11.08
ROC last 12 Months 1.99
Return on invested Capital Q 2.02
Return on invested Capital Y4.90
Assets Turnover0.50
Receivables Turnover2.70
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)15 479 000
Revenue per Share 9.49
Revenue Growth 3 Years 7.94
Revenue Growth 5 Years 4.43
DividendsValueIndustryS&P 500US Markets
Dividend Yield 2.78
Dividend Rate 1.60
Dividend Growth 3 Years2.10
Dividend Growth 5 Years-2.60

Earnings HistoryEstimateReportedSurprise %
Q02 20180.871.0116.09
Q01 20180.850.9410.59
Q04 20170.670.681.49
Q03 20170.770.75-2.60
Q02 20170.730.741.37
Q01 20170.720.8416.67
Q04 20160.660.63-4.55
Q03 20160.650.7718.46
Earnings Per EndEstimateRevision %Trend
9/2018 QR0.902.27Positive
12/2018 QR0.818.00Positive
12/2018 FY3.646.43Positive
12/2019 FY3.947.95Positive
Next Report Date25th Oct 2018
Estimated EPS Next Report0.90
Estimates Count6
EPS Growth Next 5 Years %10.10
Volume Overview
Volume6 119 906
Shares Outstanding (in ths.)1 634 540
Trades Count32 600
Dollar Volume321 710 149
Avg. Volume7 368 169
Avg. Weekly Volume8 494 234
Avg. Monthly Volume6 374 108
Avg. Quarterly Volume5 804 181

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

73%27%

Bearish Bullish

67%33%

Bearish Bullish

48%52%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (38.46 %)
5 (35.71 %)
5 (38.46 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
8 (61.54 %)
9 (64.29 %)
8 (61.54 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.23
Moderate Buy
2.29
Moderate Buy
2.23

There are no comments yet.

News

x